I-MAB

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell I-MAB and other ETFs, options, and stocks.

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China.

CEO

Jing Wu Zang

CEOJing Wu Zang

Employees

378

Employees378

Headquarters

Pudong, Shanghai

HeadquartersPudong, Shanghai

Founded

2016

Founded2016

Employees

378

Employees378

IMAB Key Statistics

Market cap

326.58M

Market cap326.58M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

427.19K

Average volume427.19K

High today

$4.04

High today$4.04

Low today

$3.80

Low today$3.80

Open price

$4.04

Open price$4.04

Volume

450.88K

Volume450.88K

52 Week high

$74.59

52 Week high$74.59

52 Week low

$3.80

52 Week low$3.80

Analyst ratings

100%

of 12 ratings

Buy

100%

Hold

Sell

IMAB Earnings

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Estimated— per share

Actual

Available Aug 30, Pre-Market

ActualAvailable Aug 30, Pre-Market

Replay Earnings Call